Abstract

Objective To describe age-sex differences in the duration from symptom onset to fatality as an outcome in coronavirus desease 2019 (COVID-19) patients. Methods The Mexican surveillance system database (up to 15th August 2020) of 70,515 death cases (45,053 males, 25,462 females) in COVID-19 was used for analysis. Age groups for pediatric patients were <1, 1-4, 5-9-years and for the adolescent and adult patients, each decade of life constituted an age group. Results Proportionally more deaths occurred among male patients (64%). Median duration was eight days from onset of symptoms until death; mean value was approximately 10-days. Distribution by age groups showed females survived lower number of average days after the onset of symptoms. A tendency of rise in the number of days survived has been observed from infancy to adulthood and a subsequent decline after 70-years of age. Conclusion Female patients survived relatively lower number of days with infection until death, compared to males.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call